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Abstract 
This study evaluated immunomodulatory properties and the sub-acute toxicity profile of two fractions 
of the aqueous alcoholic extract of the dried calyx of Hibiscus sabdariffa in experimental animals. 
Immunomodulatory activity was evaluated using red blood cell-induced immunostimulation. The fractions were 
not found to be toxic after 7-day administration, though there was severe weight loss with the residual water-
soluble fraction (RWSF) and weight gain with the ethyl acetate soluble fraction (EAC). The EAC exhibited a 
significant dose-dependent immunostimulation (p<0.05) higher than that observed for levamisole (positive 
control). The residual water-soluble fraction exhibited immunostimulatory activity at 100mg/kg body weight. 
The two fractions caused a significant reduction in production of tissue necrosis factor – alpha and an increase in 
interleukin 10 (IL-10).  
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Introduction 
The extracts and some of the constituents of dried calyx of Hibiscus sabdariffa Linn (family Malvaceae) 
have been reported to possess impressive antioxidant and antihypertensive activities in animal models and 
human, (Tseng et al., 1997; Tseng et al., 1998; Ali et al.., 2003; Lin et al., 2003; Odigie et al.., 2003; Herrera-Arellano 
et al., 2004; Amin and Hamza, 2005), and in vitro antimicrobial and in vivo anti-inflammatory activity (Ogundipe 
et al., 1998). The extracts were found at low doses to cause inhibition of serum lipids with anti-atherosclerotic 
activity (Chen et al., 2003) and induction of apoptosis (Hou et al., 2005; Chang et al, 2005; Lin et al., 2005).  
Chronic oral administration of the water and alcoholic extracts of Hibiscus sabdariffa had been found 
toxic in a previous study affecting liver function enzymes, serum creatinine and causing muscular dystrophy and 
significant weight loss in mice at 300mg and 2000mg/kg body weight doses, while the alcoholic and water 
extracts possess significant immunostimulatory and anxiolytic activities, and cause significant increase in 
ketamine-induced sleep in mice (Fakeye et al., In press, 2008). 
This study was therefore designed to evaluate the immunomodulatory properties of two fractions of the 
crude aqueous alcoholic extract of the dried calyx of Hibiscus sabdariffa. The sub-acute toxicity profile of the doses 
for the immunomodulatory activity was also evaluated. 
 
Methodology 
 
 The dried flowers of Hibiscus sabdariffa L (family Malvaceae) were purchased at the local 
market and further dried at 40 °C until a constant weight was obtained. The material was authenticated at the 
Forestry Research Institute of Nigeria (FRIN), Ibadan. A herbarium species (reference number FHI 107622) was 
submitted for future reference. The dried calyx was pulverized to obtain a coarsely powdered material. One liter 
50% ethanol (water/ethanol - 50:50) was used to infuse 100g of the powdered plant material for four hrs. The 
extract obtained was decanted and the material was re-extracted with another one L. The extracts obtained were 
pooled, filtered and dried in vacuo using a rotary evaporator. The extract was further partitioned successively 
into dichloromethane (Merck KGaA, Darmstadt, Germany), ethyl acetate (Thomas Baker Chemicals PVT Ltd, 
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Mumbai, India) and butanol (Thomas Baker Chemicals PVT Ltd, Mumbai, India). The fractions obtained were 
dried in vacuo and the yield was noted.  
 
Sub-acute toxicity tests  
 
Male swiss albino mice obtained from the animal house of Central Institute of Medicinal and Aromatic 
Plants (CIMAP), Lucknow, with weight ranging from 18 – 24 g (16.25 ± 9.85 g) were kept in laboratory cages. 
Feed and water were allowed ad libitum and the animals were maintained in standard environmental conditions 
(temperature 27 ± 1.5 0C; humidity 73 ± 2.3%) throughout the period of the study. 
Different concentrations of residual water-soluble fraction (RWSF) and the ethyl acetate-soluble 
fractions (EAC) were prepared in 20% Tween 80. To three groups of four male swiss albino mice each were 
administered 50, 100 mg/kg of the ethyl acetate-soluble fraction or 100 mg/kg body weight of the residual 
water-soluble fraction daily for seven days with oral feeding needle. Another group of four male mice were 
administered 0.8 ml of 20% Tween 80 as control. The weight of each animal was monitored over a 7-day 
observation period. The animals were closely monitored the first 24 hr post administration of the fractions. 
Thereafter, a daily observation was kept for seven days. Blood (0.7 ml) was obtained through the medial canthus 
of the mice seven days after administration of the fractions. Erythrocyte, total leukocyte and differential 
leukocyte count were determined using standard methods. Plasma was obtained by centrifuging heparinised 
blood at 2500 rpm for 10 minutes. The plasma obtained was analysed for glucose, triglycerides and creatinine 
using a RA-50 standardised Clinical Chemistry System (RA232C, Serial No 30650, Bayer Diagnostics Mfg. Ltd., 
Swords, Co. Dublin, Ireland). All experimental protocols were in compliance with CIMAP institutional Ethical 
Committee Guidelines as well as internationally accepted principles for laboratory animal use and care as found 
in US guidelines (NIH publication #85-23, revised in 1985 
 
Immunomodulatory tests 
 
This activity was evaluated using red blood cell-induced immunostimulation in swiss albino mice 
weighing 18-24 g (16.25 ± 9.85 g). Residual water soluble fraction (RSWF) at 100 mg/kg body weight and ethyl 
acetate-soluble fraction (EAC) at 50 and 100 mg/kg body weight were administered to groups of mice each with 
oral gavage needle daily for 28 days. Levamisole (0.6818 mg/kg) administered orally was used as positive 
control, while the vehicle-control group was administered 0.5 ml of water daily. The negative control group was 
administered intraperitoneal cyclophosphamide (200 mg/kg) on day 5. On day 7, 200 µl of 10% of freshly 
prepared New Zealand rabbit red blood cell (RRBC) suspension in normal saline was administered intra-
peritoneally. This was repeated 14 days later as a booster dose. On day 28, all the animals were bled and the 
serum collected was stored at -20 oC for further studies. Body weights of the animals were monitored weekly. 
To evaluate the ability of the fractions to enhance or diminish the formation of antibodies to the RRBC, 
haemaglutination test was performed by adding 100 µl of rabbit RBC (6 X 103 cells per ml) to 25 µl of the serial 
two fold dilutions of the serum in Alsever’s solution in U-bottom microtitre plates. This was shaken and allowed 
to stand for 4 hr at 25 oC. Rabbit RBC-setting patterns were then read. The haemaglutination (HA) titer was 
expressed as the reciprocal of the highest dilution of the serum showing definite agglutination formation as 
opposed to smooth dot in the center of the well. 
 
 
 
Cytokine determination 
 
Previous studies  have showed that extracts (Chen et al., 2003) and some of the fractions of the dried 
calyx possess anti-inflammatory activity in carrageenan-induced rat paw model, and were able to reduce 
production of tissue necrosis factor-α (TNF-α) and increase interleukin-10 (IL-10) production (implicated as pro-
inflammatory and anti-inflammatory interleukins respectively). Enzyme-linked immunosorbant assay (ELISA) 
for the quantitative measure of mouse TNF-α, and IL-10 (Endogen(R) Mouse ELISA kit, Pierce Biotechnology, Inc, 
Rockford) was used to evaluate the effects of the fractions on the production of the two cytokines. Sera from 
animals given the same treatment were pooled. A 50 µl of the pooled sera (from animals which had received the 
same treatment) or standard concentrations of lyophilized recombinant mouse tissue necrosis factor- alpha was 
added to biotin-labelled detecting antibody reagent in TNF-α precoated wells. Incubation was done for 2 hr at 37 
oC. Thereafter, a 100 µl dilution of 1:400 streptavidin conjugated with highly purified horseradish peroxidase was 
added to each well and further incubated for 30 mins.  
For determination of IL-10, 50 µl assay buffer was added to each endogen mouse interleukin-10 pre-
coated well. The same amount of standards (containing known concentrations of lyophilized recombinant mouse 
IL-10) or samples from the pooled sera was added to the wells and incubated at 37 oC for 3 hr. After washing the 
plates, 50 µl of biotin-labelled detecting antibody reagent was added to each well, incubated for 1 hr, after which 
100 µl of 1:400 diluted streptavidin-horse radish peroxidase was added and incubated for 30 mins.  
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To both IL-10 and TNF-α plates, 100 µl of premixed 3,3/,5,5/-tetremethylbenzidine substrate solution 
was added to each well and developed in the dark for 30 mins. The blue color obtained was stopped with 100 µl 
of 0.18M sulphuric acid. The difference in absorbance was measured using a spectrophotometer plate reader 
(Versamax, Molecular Devices, USA) at 450 nm and 550 nm. The difference in absorbance was read off the 
calibration curve obtained from the standard concentrations. The concentration of each cytokine was determined 
in picogram per milliliter of serum.   
 
 
Results and Discussion 
 
Fractionation of the crude aqueous alcoholic extract gave a yield of 5% and 18.5% for ethyl acetate-
soluble and residual water-soluble fractions respectively.  
The fractions were generally found non-toxic at the dose used to evaluate the immunomodulatory 
properties in the animals. However, the residual water-soluble fraction, RWSF, caused a severe weight loss when 
compared with the control animals. Table 1 shows the toxic effects of the fractions on some biochemical and 
hematological parameters. The ethyl acetate-soluble fraction, EAC, was found to cause an increase in the total 
leucocyte count at 100 mg/kg (p<0.05) but with a reduction at 50 mg/kg. The two fractions caused a significant 
reduction in basophils, the white blood cells responsible for antigen-antibody response. The RWSF caused a 
reduction in neutrophil count which deals with defense against bacterial infections. There was no change with 
the lymphocyte count when compared with the control group even though results obtained showed that the 
fractions enhanced the antigen-antibody reaction to the RRBC antibodies.   
The EAC soluble fraction exhibited a significant dose-dependent activity in cytokine production with 
more than a 6-fold increase in IL-10 production activity with a double increase in dose (100 mg/kg versus 50 
mg/kg; Table 2). The EAC at 100 mg/kg caused a profound reduction in the production of TNF-α while the 
RWSF (100 mg/kg) and EAC at 50 mg/kg compared with levamisole, the positive control, in the production of 
TNF-α.  
Concentrations of the TNF-α in the serum of the experimental animals, though not exhibiting dose-
dependence in any of the test groups, was lowest with EAC 100 mg/kg. Previous studies have implicated high 
levels of TNF-α in clinical diagnosis of atherosclerosis. The noticeable reduction in production of TNF-α in this 
study by EAC and RWSF confirm the activity of extracts of Hibiscus sabdariffa reducing atherosclerosis in an 
animal model (Chen et al., 2003). 
Interleukin 10 (IL-10) was highest in the serum of animals on EAC 100 mg/kg. The interplay of the 
reduction in concentration of TNF-α and increase in IL-10 has been linked with stress, inflammation and tumors. 
IL-10 has been known to down regulate factors present in inflammation 
and tumors. An extract or chemical compound that could increase anti-inflammatory interleukin, for example, 
IL-10, and reduce the formation of a pro-inflammatory factor such as TNF-α, as EAC has done, may be found to 
be of use as a source of drug candidate for preventing or reducing formation of atherosclerotic plaques and may 
also help in reduction of stress and possess antitumour activity. The low level and high level of TNF-alpha and 
IL-10 respectively confirmed that the fractions tested may also stimulate immunomodulation through the 
activities of cytokines.   
 
Conclusion 
 
Multiple doses of the fractions of the aqueous alcoholic extracts of the dried calyx of Hibiscus sabdariffa 
were not found to be toxic at the doses found to possess immunostimulatory activities. The  
fractions possess impressive immunostimulatory activities with a profound increase in production of an anti-
inflammatory cytokine, IL-10 and a great reduction in production of tissue necrosis factor – alpha. The two 
fractions, EAC and RWSF, showed good possibilities of being developed into drug entities that may be used to 
stimulate immunity as an adjunct to therapy in immunosuppressed disease conditions.  
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Table 1: Biochemical and hematological effects of sub-acute administration of fractions of Hibiscus sabdariffa in mice 
 
 
Biochemical parameters Haematological parameters ( Mean ± SD) Treatment 
(mg/kg) 
% weight 
changes CRT (mg/dL) TRIG (mg/dL) GLUC 
(mg/dL) 
Total 
WBC 
(X103) 
Lymphocyt
es 
Neutrophil
s 
Monocytes Basophils Eosinophil
s 
EAC50 9.34 ± 0.89 0.64 ± 0.05 170.22 ± 17.94 140.98 ± 
31.91 
2.53 ± 1.8 73.51 ± 1.74 15.35 ± 
2.11 
9.63 ± 3.19 1.52 ± 0.66* 0.00 
EAC100 5.67 ± 2.38 0.70 ± 0.09 148.58 ± 15.77 174.30 ± 
18.97* 
15.03 ± 
3.85* 
83.03 ± 6.99 11.32 ± 
3.35 
5.49 ± 2.12 2.89 ± 0.98* 0.00 
RWSF 100 -2.05 ± 5.85** 0.73 ± 0.08 177.35 ± 25.98 115.48 ± 
18.14 
8.85 ± 
2.69 
85.83 ± 6.18 6.79 ± 3.75 6.17 ± 1.12 1.22 ± 1.42* 0.00 
Vehicle 
Control 
(0.8ml 20% 
Tween 80) 
15.81 ± 6.85 0.45 ± 0.02 155.56 ± 22.52 100.13 ± 
16.25 
8.55 ± 
2.78 
74.56 ± 2.99  10.53 ± 
0.58  
8.77 ± 1.89 6.14 ±  0.88 0.00 
Key:  
CRT – Creatinine;   TRIG – Triglycerides;   GLUC - Glucose 
** - p< 0.01 
* - p < 0.05 
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Table 2: The immunostimulatory activities of EAC & RWSF of Hibiscus sabdariffa in a mouse model 
Parameters Treatment  
Weight 
changes (%) 
WBC 
(103) 
Mean ± 
SD 
HA Titer (Mean 
± SD) 
TNF-α 
(pg/ml) 
IL-10 
(pg/ml) 
EAC50mg/kg 8.57 ± 2.02 2.63 ± 
0.44** 
144 ± 123.59 261 6747 
EAC100mg/kg 5.20 ± 2.57* 12.6 ± 
1.35** 
928.67 ± 619** 7 14,190 
RWSF 100mg/kg -2.85 ± 2.84** 8.80 ± 
0.80 
223.5 ± 32.5 233 5219 
Levamisole 11.19 ± 2.04 8.48 ± 
2.04 
597.33 ± 
225.97 
240 9631 
Cyclophosphamide 2.56 ± 2.44 4.33 ± 
0.30 
0.00 1108 3902 
Vehicle group 16.31 ± 3.96 7.22 ± 
0.25 
0.00 1090 4132 
                 Key: ** - p<0.01 
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